Related Experiment Video

Updated: Jun 23, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.7K

Treatment-Response Prediction for Metastatic Castrate-Resistant Prostate Cancer Using PSMA PET

Loise Wairiri, Michael R Folkert

    Radiology. Imaging Cancer
    |October 31, 2025
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
    12:13

    Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

    Published on: November 19, 2019

    7.2K
    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
    05:19

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

    Published on: November 7, 2025

    651

    Related Experiment Videos

    Last Updated: Jun 23, 2026

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
    07:25

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

    Published on: March 6, 2018

    13.7K
    Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
    12:13

    Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

    Published on: November 19, 2019

    7.2K
    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
    05:19

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

    Published on: November 7, 2025

    651

    Related Concept Videos

    Positron Emission Tomography01:29

    Positron Emission Tomography

    Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
    One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

    Articles linked to this work by shared authors, journal, and citation graph.

    Thermal ablation compared to stereotactic body radiation therapy for hepatocellular carcinoma: A multicenter retrospective comparative study.

    Hepatology communications·2023

    Identifying disparities in brachytherapy delivery for locally advanced cervical cancer.

    Brachytherapy·2023

    Evaluation of leadership curricula in general surgery residency programs.

    American journal of surgery·2021

    Disparities in Characteristics, Access to Care, and Oncologic Outcomes in Young-Onset Colorectal Cancer at a Safety-Net Hospital.

    JCO oncology practice·2021

    Increasing Medical Student Engagement Through Virtual Rotations in Radiation Oncology.

    Advances in radiation oncology·2020

    Spectral CT-based Nomogram for Noninvasive Assessment and Prognostic Prediction of MSI/dMMR in Esophagogastric Junction Adenocarcinoma.

    Radiology. Imaging cancer·2026

    Robotic Needle Insertion for CT-guided Percutaneous Biopsy of Thoracoabdominal Lesions: A Prospective Multicenter Randomized Trial.

    Radiology. Imaging cancer·2026

    Proof-of-Concept Study of Hyperpolarized [1-13C]Pyruvate MRI in Participants with Hepatocellular Carcinoma.

    Radiology. Imaging cancer·2026

    Incremental Value of Synthetic MRI Radiomics in Predicting Neoadjuvant Response in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

    Radiology. Imaging cancer·2026

    HPV-associated Oropharyngeal Squamous Cell Carcinoma: An Imaging Framework for AJCC Version 9 TNM Staging.

    Radiology. Imaging cancer·2026

    Spectral CT and Photon-counting Detector CT: Principles and Applications in Neuroradiology.

    Radiology. Imaging cancer·2026

    Comparative effectiveness of GLP-1 receptor agonists versus mineralocorticoid receptor antagonists as fourth-line pharmacological therapy in patients with resistant hypertension and overweight or obesity: a retrospective multicenter cohort study in the USA.

    EClinicalMedicine·2026

    Translational modelling challenges receptor‑occupancy‑based dosing of PD‑1 inhibitors like pembrolizumab.

    British journal of cancer·2026

    Potential role of 5-HT7 receptor antagonists in the treatment of depression: Pharmacological and bioengineering perspectives.

    Progress in neuro-psychopharmacology & biological psychiatry·2026

    Discovery of potential new drug targets for cystitis and chronic cystitis: a drug target Mendelian randomization study.

    The French journal of urology·2026

    Using PDMP Data to Enhance Public Health Surveillance: Opioid and Concurrent Benzodiazepine Use in a State Medicaid Program.

    The journal of pain·2026

    A systematic review of electrophysiological markers of reward processing in addiction.

    Addictive behaviors·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us